Toggle Main Menu Toggle Search

Open Access padlockePrints

The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover

Lookup NU author(s): Dr Kelly Coffey, Lynsey Rogerson, Claudia Ryan-Munden, Dhuha Alkharaif, Dr Jacqueline Stockley, Professor Rakesh Heer, Dr Kanagasabai Sahadevan, Daniel O'Neill, Dominic Jones, Dr Steven Darby, Dr Luke GaughanORCiD, Professor Craig Robson



The androgen receptor (AR) is a key molecule involved in prostate cancer (PC) development and progression. Post-translational modification of the AR by co-regulator proteins can modulate its transcriptional activity. To identify which demethylases might be involved in AR regulation, an siRNA screen was performed to reveal that the demethylase, KDM4B, may be an important co-regulator protein. KDM4B enzymatic activity is required to enhance AR transcriptional activity; however, independently of this activity, KDM4B can enhance AR protein stability via inhibition of AR ubiquitination. Importantly, knockdown of KDM4B in multiple cell lines results in almost complete depletion of AR protein levels. For the first time, we have identified KDM4B to be an androgen-regulated demethylase enzyme, which can influence AR transcriptional activity not only via demethylation activity but also via modulation of ubiquitination. Together, these findings demonstrate the close functional relationship between AR and KDM4B, which work together to amplify the androgen response. Furthermore, KDM4B expression in clinical PC specimens positively correlates with increasing cancer grade (P < 0.001). Consequently, KDM4B is a viable therapeutic target in PC.

Publication metadata

Author(s): Coffey K, Rogerson L, Ryan-Munden C, Alkharaif D, Stockley J, Heer R, Sahadevan K, O'Neill D, Jones D, Darby S, Staller P, Mantilla A, Gaughan L, Robson CN

Publication type: Article

Publication status: Published

Journal: Nucleic Acids Research

Year: 2013

Volume: 41

Issue: 8

Pages: 4433-4446

Print publication date: 21/02/2013

Date deposited: 11/07/2013

ISSN (print): 0305-1048

ISSN (electronic): 1362-4962

Publisher: Oxford University Press


DOI: 10.1093/nar/gkt106

PubMed id: 23435229


Altmetrics provided by Altmetric


Funder referenceFunder name
Cancer Research UK
07-0822Association for International Cancer Research
C1385/A12415Cancer Research UK